Cargando…

Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up

Background: The changes in the risk of disease failure over time in nasopharyngeal carcinoma (NPC) remains unknown. Methods: We analyzed 749 patients treated with intensity-modulated radiotherapy in a single center. The annual hazard rates of disease failure (recurrence or death from any cause) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xu, Tang, Ling-Long, Du, Xiao-Jing, Li, Wen-Fei, Chen, Lei, Zhou, Guan-Qun, Guo, Rui, Liu, Qing, Sun, Ying, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332897/
https://www.ncbi.nlm.nih.gov/pubmed/28261347
http://dx.doi.org/10.7150/jca.17104
_version_ 1782511616490733568
author Liu, Xu
Tang, Ling-Long
Du, Xiao-Jing
Li, Wen-Fei
Chen, Lei
Zhou, Guan-Qun
Guo, Rui
Liu, Qing
Sun, Ying
Ma, Jun
author_facet Liu, Xu
Tang, Ling-Long
Du, Xiao-Jing
Li, Wen-Fei
Chen, Lei
Zhou, Guan-Qun
Guo, Rui
Liu, Qing
Sun, Ying
Ma, Jun
author_sort Liu, Xu
collection PubMed
description Background: The changes in the risk of disease failure over time in nasopharyngeal carcinoma (NPC) remains unknown. Methods: We analyzed 749 patients treated with intensity-modulated radiotherapy in a single center. The annual hazard rates of disease failure (recurrence or death from any cause) were estimated using the life-table method. Results: In total, 41 (5.5%), 22 (2.9%) and 129 (17.2%) patients developed local, regional and distant recurrences, respectively; 149 (19.9%) patients died. Of the 600 patients who were alive at the last follow-up, 496 (82.7%) had follow-up times longer than 6 years. The 6-year failure-free survival rate was 74.8%. Older age (> 50 years) and advanced stage (Ⅲ-ⅣB) were independent risk factors for disease failure in multivariate analysis. The hazard curve for failure risk in the whole cohort showed a sharp peak at 2 years, changed to a gradually decreasing plateau between years 3 and 5 and then declined sharply. Subgroup analyses revealed similar hazard curves in both sexes. However, the patterns of hazard curve significantly differed between high-risk (> 50 years or stage Ⅲ-ⅣB) and low-risk (≤ 50 years or stage Ⅰ-Ⅱ) patients. Interpretation: The failure hazard rate in NPC didn't decline in a linear manner, but displayed a sharp peak at 2 years. The patterns of hazard function significantly differed between patients with different age and stage. Further studies are warranted to confirm our results.
format Online
Article
Text
id pubmed-5332897
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-53328972017-03-03 Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up Liu, Xu Tang, Ling-Long Du, Xiao-Jing Li, Wen-Fei Chen, Lei Zhou, Guan-Qun Guo, Rui Liu, Qing Sun, Ying Ma, Jun J Cancer Research Paper Background: The changes in the risk of disease failure over time in nasopharyngeal carcinoma (NPC) remains unknown. Methods: We analyzed 749 patients treated with intensity-modulated radiotherapy in a single center. The annual hazard rates of disease failure (recurrence or death from any cause) were estimated using the life-table method. Results: In total, 41 (5.5%), 22 (2.9%) and 129 (17.2%) patients developed local, regional and distant recurrences, respectively; 149 (19.9%) patients died. Of the 600 patients who were alive at the last follow-up, 496 (82.7%) had follow-up times longer than 6 years. The 6-year failure-free survival rate was 74.8%. Older age (> 50 years) and advanced stage (Ⅲ-ⅣB) were independent risk factors for disease failure in multivariate analysis. The hazard curve for failure risk in the whole cohort showed a sharp peak at 2 years, changed to a gradually decreasing plateau between years 3 and 5 and then declined sharply. Subgroup analyses revealed similar hazard curves in both sexes. However, the patterns of hazard curve significantly differed between high-risk (> 50 years or stage Ⅲ-ⅣB) and low-risk (≤ 50 years or stage Ⅰ-Ⅱ) patients. Interpretation: The failure hazard rate in NPC didn't decline in a linear manner, but displayed a sharp peak at 2 years. The patterns of hazard function significantly differed between patients with different age and stage. Further studies are warranted to confirm our results. Ivyspring International Publisher 2017-02-10 /pmc/articles/PMC5332897/ /pubmed/28261347 http://dx.doi.org/10.7150/jca.17104 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Liu, Xu
Tang, Ling-Long
Du, Xiao-Jing
Li, Wen-Fei
Chen, Lei
Zhou, Guan-Qun
Guo, Rui
Liu, Qing
Sun, Ying
Ma, Jun
Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up
title Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up
title_full Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up
title_fullStr Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up
title_full_unstemmed Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up
title_short Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up
title_sort changes in disease failure risk of nasopharyngeal carcinoma over time: analysis of 749 patients with long-term follow-up
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332897/
https://www.ncbi.nlm.nih.gov/pubmed/28261347
http://dx.doi.org/10.7150/jca.17104
work_keys_str_mv AT liuxu changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT tanglinglong changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT duxiaojing changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT liwenfei changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT chenlei changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT zhouguanqun changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT guorui changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT liuqing changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT sunying changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup
AT majun changesindiseasefailureriskofnasopharyngealcarcinomaovertimeanalysisof749patientswithlongtermfollowup